Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
clinical disease » tropical disease (Expand Search), clinical cases (Expand Search)
linear decrease » linear increase (Expand Search)
Showing 141 - 160 results of 36,983 for search '(( significant ((clinical disease) OR (linear decrease)) ) OR ( significant decrease decrease ))', query time: 0.68s Refine Results
  1. 141
    MigC interacts with and decreases the activity of MurD.

    MigC interacts with and decreases the activity of MurD. by Jeanette M. Critchlow (21553796)

    Published 2025
    Save to List
    Saved in:
  2. 142
    Elevated concentrations of serum MMA among participants with decreased cognitive performance.

    Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

    Published 2025
    Save to List
    Saved in:
  3. 143
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 144
    Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period.

    Linear Mixed-Effects Model analysis of bone mineral density changes in relation to urinary cadmium levels in a 3-Year Period. by Aroon La-up (14095691)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 145
    DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx

    DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx by Teresa Fontán-Baselga (20392470)

    Published 2024
    “…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …”
    Save to List
    Saved in:
  6. 146
    The flow-diagram for the randomised clinical study.

    The flow-diagram for the randomised clinical study. by Iva Milinkovic (22331710)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 147
    TH5487 decreases RSV-induced release of lactose dehydrogenase (LDH).

    TH5487 decreases RSV-induced release of lactose dehydrogenase (LDH). by Lang Pan (5145221)

    Published 2024
    Save to List
    Saved in:
  8. 148
    Image 12_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 12_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  9. 149
    Table 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.docx

    Table 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.docx by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  10. 150
    Image 14_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 14_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  11. 151
    Image 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 1_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  12. 152
    Image 11_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 11_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  13. 153
    Image 16_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 16_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  14. 154
    Image 13_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 13_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  15. 155
    Image 3_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 3_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  16. 156
    Image 15_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 15_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  17. 157
    Image 2_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 2_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  18. 158
    Image 10_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif

    Image 10_Decreased neuronal and increased endothelial fractalkine expression are associated with neuroinflammation in Parkinson’s disease and related disorders.tif by Yaping Chu (789771)

    Published 2025
    “…Introduction<p>Chronic neuroinflammation is a persistent feature of individuals with Parkinson’s disease (PD). Dopaminergic neurodegeneration is partially associated with neuroinflammation. …”
    Save to List
    Saved in:
  19. 159
    GLS inhibition decreases IL-1β secretion <i>in vitro</i>.

    GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

    Published 2025
    Save to List
    Saved in:
  20. 160
    Data Sheet 2_An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-moderate probable Alzheimer's disease.xlsx

    Data Sheet 2_An exploratory analysis of bezisterim treatment associated with decreased biological age acceleration, and improved clinical measure and biomarker changes in mild-to-m... by Christopher L. Reading (21236861)

    Published 2025
    “…</p>Methods<p>In a 7-month, randomized, double-blind, placebo-controlled trial (NCT04669028), we investigated the safety and activity of bezisterim, a first-in-class, oral, blood–brain barrier–permeable, anti-inflammatory agent on cognitive, molecular, biochemical, physiological, and biological aging parameters in a subset of 50 mild-to-moderate probable Alzheimer's disease participants. These participants had source-document-verified clinical measures and samples, and they completed the protocol. …”
    Save to List
    Saved in:

Search Tools: